Cymru Law Partners, Legal Research Collaborations
Learn how to become a researcher, explore academic and legal research, qualifications, SQE work experience and Cymru Law Partners’ inclusive mission.
Renewing a Medical Driving Licence in the UK
Understand UK medical driving licence renewal rules for MS and disability, DVLA revocation, medical assessments, legal rights and appeals.
Cymru Law Partners: From Lived Experience to Legal Empowerment
How Renata Maziak Barnes is combining decades of entrepreneurship, digital marketing, disability advocacy and legal education to build a platform dedicated to knowledge, opportunity and access to justice.
AI-Powered Law Firms Draw Lawyers from Big Firms
How AI-native law firms are challenging traditional legal practices, creating opportunities for newly qualified lawyers and changing the future of legal entrepreneurship.
How Market Research Companies Can Attract High-Paying Clients
Discover how lawyers use market research agencies and how research companies can attract premium clients through SEO, marketing, networking and strategic partnerships.
Cell and Gene Therapy AI (CGTAI): How Artificial Intelligence and Gene Editing Could Transform Medicine
Discover how Cell and Gene Therapy AI (CGTAI), CRISPR gene editing and advanced cell therapies could transform treatments for autoimmune and genetic diseases.
Dementia Awareness: Can We Prevent Memory Loss?
Can dementia be prevented or reversed? Explore early symptoms, memory loss, brain exercises, medical treatments, holistic therapies and ways to support older relatives.
Can Iodine Deficiency Affect Injury Recovery?
Recovering from an injury involves much more than rest and rehabilitation. The body relies on proper nutrition to repair tissues, regulate inflammation, support energy production, and promote overall healing. While nutrients such as protein, vitamin C, and zinc often receive the most attention, iodine also plays an important role in maintaining bodily functions that can influence recovery.
Kamuvudine-9 and Multiple Sclerosis
Multiple sclerosis research has produced an intriguing new development following the publication of a study involving an experimental medicine called kamuvudine-9, also known as K-9. Researchers have reported that K-9 was able not only to prevent further neurological deterioration in a laboratory model of multiple sclerosis but also to reverse existing paralysis and vision loss in mice.
Natalizumab for Multiple Sclerosis: Understanding Treatment Options
Natalizumab is a highly effective treatment for active multiple sclerosis, but what are the risks of JC virus and PML? We examine natalizumab, JCV testing, PML monitoring, ocrelizumab, ofatumumab, ublituximab, cladribine and AHSCT stem-cell transplantation.